FPN is continuing its campaign to make funding available for research on peripheral neuropathy. We need your help… again!
FPN (and the scientific community) were pleased to see that over $8 million in grant funding was awarded to research focused on peripheral neuropathy under the Department of Defense’s (DoD) Peer Reviewed Medical Research Program (PRMRP) for 2021.
We were equally pleased to see the action taken by Congress to designate “peripheral neuropathy” as a condition eligible for research funding under the PRMRP again for 2022.
Some patients with “long COVID” have incident neuropathy, according to a study published in Neurology: Neuroimmunology & Neuroinflammation.
Dr. Anne Louise Oaklander, M.D., Ph.D., from Massachusetts General Hospital in Boston, and colleagues analyzed cross-sectional and longitudinal data from patients with World Health Organization-defined long COVID without a prior neuropathy history or risks who were referred for assessment of peripheral neuropathy. Seventeen patients were tracked for 1.4 years on average.
The researchers found that 59 percent of the participants had one or more test interpretations confirming neuropathy.